ஜேன் நம்பிக்கை அடித்தளம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜேன் நம்பிக்கை அடித்தளம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜேன் நம்பிக்கை அடித்தளம் Today - Breaking & Trending Today

Antihypertension drug may help patients with noncancerous brain tumors affecting hearing

Antihypertension drug may help patients with noncancerous brain tumors affecting hearing
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

United States , Jie Chen , Scottr Plotkin , Jun Ren , Lukasd Landegger , Meenal Datta , Sasa Vasilijic , Alona Muzikansky , Dorothea Buckler , Wenjianlong Zhou , Rakeshk Jain , Xing Gao , Yanling Zhang , Limeng Wu , Yao Sun , Alyssa Brown , Jessicae Sagers , Luo Zhang , Konstantina Stankovic , National Cancer Institute , Department Of Defense , National Foundation For Cancer , Cancer Research Institute , Barnes Foundation , Division Of Otology , Lustgarten Foundation ,

Tumor-promoting immune cells retrained to fight most aggressive type of brain cancer

E-Mail
BOSTON - It s a real-life plot worthy of a classic spy novel: Researchers at Massachusetts General Hospital (MGH), the Dana-Farber Cancer Institute and other Boston-area research centers are turning the tables on glioblastomas, the most devastating and aggressive form of brain cancer, by transforming a type of cell that normally protects tumors and inhibits effective drug therapy into a stone-cold glioblastoma killer.
Glioblastoma, a type of brain tumor, is rapidly fatal: Most patients die within two years of diagnosis despite aggressive therapies such as brain surgery, whole-brain radiation and chemotherapy.
Despite hopes that a class of drugs known as immune checkpoint blockers (ICBs) - drugs that have revolutionized the treatment of patients with malignant melanoma, non-small-cell lung cancer, and other solid tumors - could also benefit patients with glioblastoma, ICBs have not been effective against the disease in clinical trials to date. ....

United States , Dana Farber Cancer Institute , Edwinl Steele , Rakeshk Jain , Hye Jung Kim , Zohreh Amoozgar , Dai Fukumura , Nature Communications , Jane Trust Foundation , National Institutes Of Health , Harvard Medical School , National Foundation For Cancer Research , Research Institute , Harvard Ludwig Cancer Center , Department Of Radiation Oncology , Research Foundation , Massachusetts General Hospital , Radiation Oncology , Andrew Werk Cook Professor , Dana Farber Cancer , National Institutes , National Foundation , Cancer Research , Advanced Medical Research Foundation , Harvard Medical , Mass General Research Institute ,

Potential new treatment strategy for breast cancer cells that have spread to the brain

E-Mail
BOSTON - New research reveals that when breast cancer cells spread to the brain, they must boost production of fatty acids, the building blocks of fat, in order to survive there. The work, which is published in
Nature Cancer and was led by investigators at Massachusetts General Hospital (MGH) and the Koch Institute of the Massachusetts Institute of Technology (MIT), points to a potential new treatment target for shrinking brain tumors that arise secondary to breast cancer.
Therapies that target the human epidermal growth factor receptor 2 (HER2) have transformed treatment for patients with breast cancer whose tumor cells express HER2, but brain metastases from this disease are typically fatal because they are resistant to anti-cancer therapies that are effective in other locations in the body. This is in part due to the blood-brain barrier that protects the brain against circulating toxins and pathogens, but changes in the cancer cells once they reach the bra ....

United States , Susang Komen , Gino Ferraro , Rakeshk Jain , Matthew Vander Heiden , Broad Institute , Jane Trust Foundation , Koch Institute , Alice Wallenberg Foundation , Ludwig Center At Harvard , National Science Foundation , Emerald Foundation , National Foundation For Cancer Research , Ludwig Center , Molecular Oncology Fund , Novo Nordisk Foundation , Research Foundation , Nature Cancer , Massachusetts General Hospital , Massachusetts Institute , Tumor Biology , Andrew Werk Cook Professor , Radiation Oncology , Harvard Medical , National Foundation , Cancer Research ,

Ideas, Inventions And Innovations : COVID-19 Unmasked: Math Model Suggests Optimal Treatment Strategies

Ideas, Inventions And Innovations
COVID-19 Unmasked: Math Model Suggests Optimal Treatment Strategies
A biology-based mathematical model indicates why COVID-19 outcomes vary widely and how therapy can be tailored to match the needs of specific patient groups.
Getting control of COVID-19 will take more than widespread vaccination; it will also require better understanding of why the disease causes no apparent symptoms in some people but leads to rapid multi-organ failure and death in others, as well as better insight into what treatments work best and for which patients.

Credit: CDC/ Alissa Eckert, MS; Dan Higgins, MAMS
To meet this unprecedented challenge, researchers at Massachusetts General Hospital (MGH), in collaboration with investigators from Brigham and Women s Hospital and the University of Cyprus, have created a mathematical model based on biology that incorporates information about the known infectious machinery of SARS-CoV-2, the virus that ....

United States , Dan Higgins , Mohammad Reza Nikmaneshi , Alissa Eckert , Edwinl Steele , Sayon Dutta , Triantafyllos Stylianopoulos , Chrysovalantis Voutouri , Rakeshk Jain , Katie Marquedant , Lancel Munn , C Corey Hardin , Ashish Verma , Melinj Khandekar , Ankitb Patel , Jane Trust Foundation , National Institutes Of Health , Harvard Medical School , National Foundation For Cancer Research , Sharif University Of Technology , Proceedings Of The National Academy Sciences , Harvard Ludwig Cancer Center , American Medical Research Foundation , University Of Cyprus , European Research Council , Department Of Radiation Oncology ,

Math model suggests optimal coronavirus treatment strategies

Getting control of COVID-19 will take more than widespread vaccination; it will also require better understanding of why the disease causes no apparent symptoms in some people but leads to rapid multi-organ failure and death in others, as well as better insight into what treatments work best and for which patients.
To meet this unprecedented challenge, researchers at Massachusetts General Hospital (MGH), in collaboration with investigators from Brigham and Women’s Hospital and the University of Cyprus, have created a mathematical model based on biology that incorporates information about the known infectious machinery of SARS-CoV-2, the virus that causes COVID-19, and about the potential mechanisms of action of various treatments that have been tested in patients with COVID-19. ....

United States , Mohammad Reza Nikmaneshi , Edwinl Steele , Sayon Dutta , Triantafyllos Stylianopoulos , Chrysovalantis Voutouri , Rakeshk Jain , Lancel Munn , C Corey Hardin , Ashish Verma , Melinj Khandekar , Ankitb Patel , Jane Trust Foundation , National Institutes Of Health , Harvard Medical School , National Foundation For Cancer Research , Sharif University Of Technology , Proceedings Of The National Academy Sciences , Harvard Ludwig Cancer Center , American Medical Research Foundation , University Of Cyprus , European Research Council , Department Of Radiation Oncology , Innovation Foundation , Cyprus Research , Massachusetts General Hospital ,